IL135823A0 - Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor - Google Patents

Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor

Info

Publication number
IL135823A0
IL135823A0 IL13582398A IL13582398A IL135823A0 IL 135823 A0 IL135823 A0 IL 135823A0 IL 13582398 A IL13582398 A IL 13582398A IL 13582398 A IL13582398 A IL 13582398A IL 135823 A0 IL135823 A0 IL 135823A0
Authority
IL
Israel
Prior art keywords
nucleic acid
acid molecule
isolated nucleic
molecule encoding
uses therefor
Prior art date
Application number
IL13582398A
Other languages
English (en)
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP006297 external-priority patent/AUPO006297A0/xx
Priority claimed from AUPP0812A external-priority patent/AUPP081297A0/en
Application filed by Univ Australian filed Critical Univ Australian
Publication of IL135823A0 publication Critical patent/IL135823A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166—Heparanase (3.2.1.166)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13582398A 1997-10-28 1998-10-28 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor IL135823A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP006297 AUPO006297A0 (en) 1997-10-28 1997-10-28 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
AUPP0812A AUPP081297A0 (en) 1997-12-09 1997-12-09 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therfor ii
PCT/AU1998/000898 WO1999021975A1 (en) 1997-10-28 1998-10-28 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor

Publications (1)

Publication Number Publication Date
IL135823A0 true IL135823A0 (en) 2001-05-20

Family

ID=25645639

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13582398A IL135823A0 (en) 1997-10-28 1998-10-28 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor

Country Status (9)

Country Link
US (1) US6242238B1 (xx)
EP (1) EP1032656A4 (xx)
JP (1) JP2002510462A (xx)
CN (1) CN1280613A (xx)
AU (1) AU744655B2 (xx)
BR (1) BR9813296A (xx)
CA (1) CA2307830A1 (xx)
IL (1) IL135823A0 (xx)
WO (1) WO1999021975A1 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348344B1 (en) * 1997-09-02 2002-02-19 Insight Strategy & Marketing Ltd. Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
US6177545B1 (en) 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6562950B2 (en) * 1997-09-02 2003-05-13 Insight Strategy & Marketing Ltd. Heparanase activity neutralizing anti-heparanase monoclonal antibody
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US5968822A (en) * 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
GB9802725D0 (en) * 1998-02-09 1998-04-08 Ciba Geigy Ag Organic compounds
US20020068054A1 (en) * 2000-09-11 2002-06-06 Insight Strategy & Marketing Ltd. And Hadasit Medical Research Services And Development Ltd. Therapeutic and cosmetic uses of heparanases
EP1157118A4 (en) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS
KR20020028906A (ko) * 1999-06-25 2002-04-17 추후보정 폴리누클레오티드 및 그에 의해 코딩된 헤파라나제와간접적으로 유사한 폴리펩티드
EP1214423A1 (en) * 1999-09-23 2002-06-19 MERCK PATENT GmbH Heparanase-2, a member of the heparanase protein family
CA2393855A1 (en) * 1999-12-22 2001-06-28 Oxford Glycosciences (Uk) Ltd. Homologues of human heparanase and splice variants thereof
IL149506A0 (en) * 1999-12-23 2002-11-10 Schering Ag Human heparanase-related polypeptide and nucleic acid
GB0008912D0 (en) * 2000-04-11 2000-05-31 Janssen Pharmaceutica Nv Mammalian heparanase
PL366012A1 (en) 2000-09-15 2005-01-24 Reddy Us Therapeutics, Inc. Methods and compositions for glycosidase assays
US6677137B2 (en) * 2000-09-20 2004-01-13 Insight Strategy & Marketing Ltd. Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity
WO2002032283A2 (en) * 2000-10-17 2002-04-25 Insight Strategy And Marketing Ltd. Methods of and pharmaceutical compositions for improving implantation of embryos
US20040033218A1 (en) * 2000-12-19 2004-02-19 Oron Yacoby-Zeevi Use of ecm degrading enzymes for the improvement of cell transplantation
US6630295B2 (en) * 2001-01-04 2003-10-07 Insight Strategy & Marketing Ltd. High throughput assay for monitoring polycation or polyanion molecular weight, degradation or synthesis
US20040247577A1 (en) * 2001-07-13 2004-12-09 Peter Bohlen Method and composition for inhibiting heparanase activity
CA2453566A1 (en) * 2001-07-13 2003-01-23 Imclone Systems Incorporated Method and composition for inhibiting heparanase activity
US7314733B2 (en) * 2001-11-13 2008-01-01 Albert Einstein College Of Medicine Of Yeshiva University Saitohin gene and uses of same
EP1522527A1 (en) * 2002-06-21 2005-04-13 Sanden Corporation Mineral water making apparatus
AU2003295411A1 (en) * 2002-11-07 2004-06-03 Celltech R & D Human monoclonal antibodies to heparanase
EP1479764A1 (en) 2003-05-19 2004-11-24 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Heparanase-derived peptides for vaccination of tumor patients
IL162276A0 (en) * 2004-06-01 2005-11-20 Hadasit Med Res Service Nucleic acid molecules as heparanase potent inhibitors, compositions and methods of use thereof
CN100462432C (zh) * 2006-03-15 2009-02-18 中国人民解放军军事医学科学院野战输血研究所 杂交瘤细胞株及其产生的抗人肝素酶单克隆抗体
US20220227889A1 (en) * 2019-04-30 2022-07-21 Encodia, Inc. Methods and reagents for cleavage of the n-terminal amino acid from a polypeptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05509403A (ja) 1990-05-31 1993-12-22 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム マウスおよびヒトメラノーマ（黒色腫）中のヘパラナーゼの免疫化学的方法による位置確定
JPH09504422A (ja) * 1993-07-29 1997-05-06 ジ・アップジョン・カンパニー 抗ヘパラナーゼ化合物を同定し、単離するためのヘパラナーゼの使用
TW565614B (en) 1996-07-18 2003-12-11 Univ Australian Detection of mammalian heparanase activity and purification of mammalian heparanase
US5968822A (en) * 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells

Also Published As

Publication number Publication date
WO1999021975A1 (en) 1999-05-06
CA2307830A1 (en) 1999-05-06
EP1032656A4 (en) 2002-10-29
CN1280613A (zh) 2001-01-17
US6242238B1 (en) 2001-06-05
AU744655B2 (en) 2002-02-28
EP1032656A1 (en) 2000-09-06
JP2002510462A (ja) 2002-04-09
BR9813296A (pt) 2000-08-22
AU1010999A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
IL135823A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
GB9710807D0 (en) Nucleic acid binding proteins
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
IL130886A0 (en) Nucleic acid sequencing
IL133582A0 (en) Mammalian neuro-growth factor like protein
EP1001964A4 (en) TANGO-78, TANGO-79 AND TANGO-81 NUCLEIC ACID MOLECULES
IL138216A0 (en) Novel fdrg protein and nucleic acid molecules and uses therefor
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
EP1051427A4 (en) SPOIL PROTEINS AND NUCLEIC ACIDS AND ITS APPLICATION
EP1071749A4 (en) NUCLEIC ACID AND LRSG PROTEIN MOLECULES AND USES THEREOF
AU3977699A (en) Ags proteins and nucleic acid molecules and uses therefor
EP1109824A4 (en) BAG PROTEINS AND NUCLEIC ACID MOLECULES ENCODING THEM
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
IL136988A0 (en) Novel nucleic acid and polypeptide
GB9701710D0 (en) Mammalian protein
ZA9811354B (en) Novel flea epoxide hydrolase nucleic acid molecules proteins and uses thereof
EP1040183A4 (en) Nucleic acid coding for mammal UBR1
EP1007682A4 (en) INNOVATIVE NUCLEIC ACID MOLECULES AND THEIR USE
AUPO006297A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
EP1012160A4 (en) TANGO-72 AND TANGO-77 NUCLEIC ACID AND POLYPEPTID MOLECULES
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor
AU4826899A (en) Novel msp-5 protein and nucleic acid molecules and uses therefor
EP1066310A4 (en) NEOKIN PROTEINS AND NUCLEIC ACIDS AND THEIR USE
AUPP081297A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therfor ii